Qilian International Holding Group Limited (QLI)

Market Cap	24.23M
Revenue (ttm)	46.47M
Net Income (ttm)	-7.78M
Shares Out	35.75M
EPS (ttm)	-0.22
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,545
Open	0.670
Previous Close	0.671
Day's Range	0.631 - 0.730
52-Week Range	0.355 - 1.280
Beta	1.52
Analysts	n/a
Price Target	n/a
Earnings Date	May 14, 2024

About QLI

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solu...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Jan 12, 2021
• Employees: 298
• Stock Exchange: NASDAQ
• Ticker Symbol: QLI